---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-274395"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2024-12-10T23:59:59+00:00"
generated_at: "2026-05-29T05:14:48.146366+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma authorizes 5M shares of preferred stock, effective Dec 9, 2024

## Summary
- Stockholders approved at Dec 4, 2024 annual meeting; amendment effective Dec 9, 2024.
- Authorizes 5,000,000 shares of preferred stock, par value $0.0001, and corresponding increase in capital stock.
- Amendment filed with Delaware Secretary of State; copy attached as Exhibit 3.1.
- No specific use of proceeds or plan for issuance disclosed in the filing.

## SEC filing metadata
- accession: 0001193125-24-274395
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2024-12-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312524274395/0001193125-24-274395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312524274395/d919024d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-274395
- JSON: https://secwatch.observer/filing/0001193125-24-274395.json
- Plain text: https://secwatch.observer/filing/0001193125-24-274395.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.